Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
How to watch 2026 Golden Globe winners like 'One Battle After Another,' 'Adolescence' and 'The Pitt'- Track down Your Optimal Conservative Vehicle: Famous Brands to Consider
- Addressing sleep apnea early might decrease chances of developing Parkinson's disease
- Nearly 16,000 New York City nurses prepare to strike as contract talks stall
- Fabricated statement about Malaysian national exam top scorers stokes racial sentiment
- A rare whale is having an encouraging season for births. Scientists warn it might still go extinct
- Exploring the School Application Cycle: Understudy Bits of knowledge
- The Rhythms of the Street: Shipping's Tune in the Economy's Symphony
- Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
